IMRT 2017

RECTAL CANCER

NCCN • IMRT should only be used in the setting of a clinical trial or unique clinical situations or anatomical situations • NEOADJUVANT • 45 to 50.4 Gy to the pelvis in 25-28 fractions • Followed by boost of 5.4 Gy in 3 fractions to the tumor bed • ADJUVANT